Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.

Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grötzinger C.

Nat Biotechnol. 2001 Apr;19(4):327-31.

PMID:
11283589
2.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

3.

Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.

Wang W, Ke S, Wu Q, Charnsangavej C, Gurfinkel M, Gelovani JG, Abbruzzese JL, Sevick-Muraca EM, Li C.

Mol Imaging. 2004 Oct;3(4):343-51.

PMID:
15802051
4.

Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.

Miao Z, Ren G, Liu H, Jiang L, Cheng Z.

J Biomed Opt. 2010 May-Jun;15(3):036007. doi: 10.1117/1.3432738.

PMID:
20615009
5.

A receptor-targeted near-infrared fluorescence probe for in vivo tumor imaging.

Tung CH, Lin Y, Moon WK, Weissleder R.

Chembiochem. 2002 Aug 2;3(8):784-6. No abstract available.

PMID:
12203978
6.

Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes.

Licha K, Hessenius C, Becker A, Henklein P, Bauer M, Wisniewski S, Wiedenmann B, Semmler W.

Bioconjug Chem. 2001 Jan-Feb;12(1):44-50.

PMID:
11170364
7.

Optical molecular imaging of lymph nodes using a targeted vascular contrast agent.

Licha K, Debus N, Emig-Vollmer S, Hofmann B, Hasbach M, Stibenz D, Sydow S, Schirner M, Ebert B, Petzelt D, Bührer C, Semmler W, Tauber R.

J Biomed Opt. 2005 Jul-Aug;10(4):41205.

PMID:
16178629
8.

Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R.

Invest Radiol. 2000 Aug;35(8):479-85.

PMID:
10946975
9.

Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.

Waldeck J, Häger F, Höltke C, Lanckohr C, von Wallbrunn A, Torsello G, Heindel W, Theilmeier G, Schäfers M, Bremer C.

J Nucl Med. 2008 Nov;49(11):1845-51. doi: 10.2967/jnumed.108.052514. Epub 2008 Oct 16.

10.

2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia.

Okuda K, Okabe Y, Kadonosono T, Ueno T, Youssif BG, Kizaka-Kondoh S, Nagasawa H.

Bioconjug Chem. 2012 Mar 21;23(3):324-9. doi: 10.1021/bc2004704. Epub 2012 Feb 22.

PMID:
22335430
11.

Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.

Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH.

Bioconjug Chem. 2003 May-Jun;14(3):539-45.

PMID:
12757377
12.

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Achilefu S, Jimenez HN, Dorshow RB, Bugaj JE, Webb EG, Wilhelm RR, Rajagopalan R, Johler J, Erion JL.

J Med Chem. 2002 May 9;45(10):2003-15.

PMID:
11985468
13.

A clearer vision for in vivo imaging.

Weissleder R.

Nat Biotechnol. 2001 Apr;19(4):316-7. No abstract available.

PMID:
11283581
14.

Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice.

Bloch S, Lesage F, McIntosh L, Gandjbakhche A, Liang K, Achilefu S.

J Biomed Opt. 2005 Sep-Oct;10(5):054003.

PMID:
16292963
15.

A review of NIR dyes in cancer targeting and imaging.

Luo S, Zhang E, Su Y, Cheng T, Shi C.

Biomaterials. 2011 Oct;32(29):7127-38. doi: 10.1016/j.biomaterials.2011.06.024. Epub 2011 Jul 2. Review.

PMID:
21724249
16.

Quantifying molecular specificity of alphavbeta3 integrin-targeted optical contrast agents with dynamic optical imaging.

Gurfinkel M, Ke S, Wang W, Li C, Sevick-Muraca EM.

J Biomed Opt. 2005 May-Jun;10(3):034019.

PMID:
16229663
17.

Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferrin.

Becker A, Riefke B, Ebert B, Sukowski U, Rinneberg H, Semmler W, Licha K.

Photochem Photobiol. 2000 Aug;72(2):234-41.

PMID:
10946578
18.

A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.

Zhang C, Liu T, Su Y, Luo S, Zhu Y, Tan X, Fan S, Zhang L, Zhou Y, Cheng T, Shi C.

Biomaterials. 2010 Sep;31(25):6612-7. doi: 10.1016/j.biomaterials.2010.05.007. Epub 2010 Jun 9.

PMID:
20542559
19.

Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.

Zheng X, Xing D, Zhou F, Wu B, Chen WR.

Mol Pharm. 2011 Apr 4;8(2):447-56. doi: 10.1021/mp100301t. Epub 2011 Jan 14.

PMID:
21197955
20.

A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo.

Masotti A, Vicennati P, Boschi F, Calderan L, Sbarbati A, Ortaggi G.

Bioconjug Chem. 2008 May;19(5):983-7. doi: 10.1021/bc700356f.

PMID:
18429627

Supplemental Content

Support Center